COMMUNIQUÉS West-GlobeNewswire

-
Turning Point Therapeutics’ CEO to Present at Goldman Sachs 40th Annual Global Healthcare Conference
04/06/2019 -
Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer
04/06/2019 -
Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia
04/06/2019 -
Myovant Sciences to Present at Upcoming June Investor Conferences
04/06/2019 -
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System
04/06/2019 -
Caladrius Biosciences Completes Enrollment in Phase 2 ESCaPE-CMD Trial for Coronary Microvascular Dysfunction
04/06/2019 -
Catalyst Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
04/06/2019 -
Philips and University of Vermont Health Network sign 10-year agreement to improve patient care
04/06/2019 -
Progressive Care Inc. Completes Acquisition of Family Physicians Rx
04/06/2019 -
Rafael Pharmaceuticals to Present at the 2019 Jefferies Global Healthcare Conference
04/06/2019 -
BeyondSpring to Present at the Jefferies 2019 Healthcare Conference
04/06/2019 -
Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology
04/06/2019 -
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019
04/06/2019 -
ASLAN Pharmaceuticals Completes Phase 1 Study for ASLAN004 Targeting Atopic Dermatitis
04/06/2019 -
Allena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders
04/06/2019 -
Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site
04/06/2019 -
Allogene Therapeutics Announces FDA Clearance of the IND for ALLO-715, a BCMA Allogeneic CAR T (AlloCAR T™) Therapy
04/06/2019 -
NexoBrid® Receives Marketing Authorization from Peru’s Ministry of Health
04/06/2019 -
TG Therapeutics to Present at the Jefferies 2019 Healthcare Conference
04/06/2019
Pages